ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
58 hedge funds and large institutions have $23.7M invested in ENZON PHARMACEUTICALS INC in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 5 closing their positions.
2,800% more call options, than puts
Call options by funds: $29K | Put options by funds: $1K
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
16% more capital invested
Capital invested by funds: $20.5M → $23.7M (+$3.18M)
9% more funds holding
Funds holding: 53 → 58 (+5)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.82M |
| 2 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$531K |
| 3 |
SIM
Spark Investment Management
New York
|
+$209K |
| 4 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$140K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$991K |
| 2 |
CSC
Cove Street Capital
El Segundo,
California
|
-$755K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$278K |
| 4 |
AWW
Alan W. Weber
|
-$223K |
| 5 |
Millennium Management
New York
|
-$147K |
ENZN Hedge Fund Activity: Q2 2015 in Review
58 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2015, worth a combined $23.7M — up 16% from $20.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ENZN positions and 5 closed out — a net gain of 5 holders — while 13 added to existing stakes and 15 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.82M. The largest seller was Brandes Investment Partners, cutting an estimated $991K.
- 58 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2015, up from 53 in Q1 2015.
- Funds reported $23.7M of ENZON PHARMACEUTICALS INC stock for Q2 2015, up 16% quarter-over-quarter.
- 10 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2015 and 5 closed out, a net change of +5 holders.
- The largest ENZON PHARMACEUTICALS INC buyer in Q2 2015 was Renaissance Technologies, an estimated $1.82M added.
- The largest ENZON PHARMACEUTICALS INC seller in Q2 2015 was Brandes Investment Partners, an estimated $991K sold.
Based on aggregated 13F filings for Q2 2015.